SVRA - Savara Pharma Bozor qiymati
Savara Inc. (SVRA) kamyob o'pka kasalliklari terapiyalariga yo'naltirilgan tor doiradagi faoliyati tufayli zaifligicha qolmoqda, bunda FDA tomonidan har qanday keshiktirishlar aksiyalar narxlarining qulashi bilan bog'liq xavf tug'diradi. Kompaniyaga tegishli taqdir, savdolarning butunlay yo'qligi va mablag'lar yetishmasligi fonida, yagona asosiy tadqiqot natijalariga bog'liqdir. 0.97 darajasida qayd etilgan bozor narxlari dinamikasi pul oqimi yetishmovchiligi va inhalatorning qimmat yakuniy sinovlari davomida kapitalning asta-sekin kamayishini tasdiqlaydi.
Savara Pharma (SVRA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi statistikasi:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Savara Inc.|SVRA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Savara Inc.|SVRA - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Savara Pharma|SVRA - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Savara|Tezkor likvidlik koeffitsiyenti savarapharma.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
SVRA - Sof foyda|Kelajakdagi foyda Savara Inc.|SVRA - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Savara Corp|SVRA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Savara Pharma|SVRA - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Savara|SVRA - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi savarapharma.com|SVRA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Savara Inc.
Kompaniyaning fundamental tahlili:SVRA (Savara)
Savara Inc. (SVRA) noyob o'pka patologiyalarini davolashda yuqori obro'ga ega, bu esa kompaniyaning joriy bozor kapitalizatsiyasida aks etganidek, bevosita investitsiya jozibadorligiga aylanadi. Ushbu ko'rsatkich barcha aksiyalarning umumiy bozor qiymatini o'lchaydi, likvidlilik oqimlarini va bozorning Fed pul-kredit siyosatiga bo'lgan reaksiyasini qamrab oladi, shu tariqa biznesning fundamental ko'lamini va aktivlarning potentsial korreksiyasi xatarlarini baholash imkonini beradi.
Muhim raqobatchilar
argenx - Bozor bahosi|BioNTech Inc. - Bozor qiymati|ABVX - Bozor qiymati|Bozor qiymati ADMA (ADMA Corp)|PTGX: Bozor kapitallashuvi|immunovant.com (IMVT) - Bozor kapitallashuvi|Bozor qiymati Kiniksa|Grifols SA - Bozor bahosi|Bozor kapitallashuvi ADPT|CLDX (Celldex Corp) - Bozor qiymati|Bozor kapitallashuvi AUPH (Aurinia Pharmaceuticals)|Bozor kapitallashuvi biocryst.com BCRX|VERA - Bozor qiymati|Bozor qiymati DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Bozor qiymati|Bozor bahosi AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi precigen.com|Bozor bahosi PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Bozor qiymati|Bozor kapitallashuvi UPB (Upstream Bio Corp)|Bozor kapitallashuvi Zenas Corp (ZBIO)|IMNM - Bozor qiymati|gossamerbio.com (GOSS) - Bozor bahosi|KalVista Pharmaceuticals, Inc. (KALV) - Bozor qiymati|Bozor bahosi Septerna, Inc.|Bozor bahosi PVLA|Bozor kapitallashuvi Rigel Corp|Bozor qiymati AnaptysBio, Inc. (ANAB)|astriatx.com - Bozor kapitallashuvi|Bozor kapitallashuvi ENGN (enGene)|rapt.com (RAPT) - Bozor qiymati|JBIO - Bozor qiymati|Bozor kapitallashuvi Aclaris Therapeutics, Inc ACRS|KYTX: Bozor kapitallashuvi|tizianalifesciences.com (TLSA) - Bozor kapitallashuvi|Bozor bahosi CABA|Bozor qiymati VTYX|Bozor kapitallashuvi THTX|Bozor kapitallashuvi Avalo Therapeutics Inc (AVTX)|Bozor qiymati Eledon Pharmaceuticals ELDN|Bozor qiymati AGEN|Climb Bio - Bozor kapitallashuvi|ZURA - Bozor kapitallashuvi|ATYR (aTyr) - Bozor bahosi|Adagene Inc. - Bozor qiymati|IMA (ImageneBio) - Bozor kapitallashuvi|Shattuck Therapeutics (STTK) - Bozor kapitallashuvi|Bozor qiymati Equillium, Inc. (EQ)|connectbiopharm.com - Bozor kapitallashuvi|Bozor kapitallashuvi IMUX (Immunic)|ATRA - Bozor bahosi|IFRX: Bozor bahosi|Bozor kapitallashuvi x4pharma.com XFOR|adicetbio.com (ACET) - Bozor qiymati|CELU - Bozor kapitallashuvi|Bozor bahosi INMB|Bozor qiymati BRNS|Bozor qiymati Kezar Life Sciences (KZR)|SABS (sabbiotherapeutics.com) - Bozor qiymati|Bozor kapitallashuvi AKTX (Akari Therapeutics Plc)|Bozor kapitallashuvi Enlivex Therapeutics Ltd ENLV|QTTB - Bozor qiymati|Bozor bahosi GOVX|EDSA: Bozor kapitallashuvi|ibioinc.com - Bozor qiymati|CARM (Carisma Therapeutics Inc) - Bozor kapitallashuvi|Bozor kapitallashuvi XTL Biopharmaceuticals Ltd|Bozor qiymati Bolt Biotherapeutics (BOLT)|HCWB (hcwbiologics.com) - Bozor qiymati|Bozor qiymati Aptevo Therapeutics Inc. APVO|AIM - Bozor bahosi|Aditxt Corp - Bozor kapitallashuvi|GRI - Bozor kapitallashuvi|XRTX (XORTX) - Bozor bahosi|Vyome Therapeutics - Bozor qiymati|REVB (Revelation Biosciences) - Bozor kapitallashuvi|indaptusrx.com (INDP) - Bozor kapitallashuvi|Bozor qiymati Scinai Immunotherapeutics Ltd. (SCNI)|Bozor bahosi calcimedica.com CALI|Bozor qiymati Affimed N.V. AFMD|ALLK - Bozor bahosi|HOOK: Bozor bahosi|IGMS - Bozor kapitallashuvi|iTeos Therapeutics, Inc. (ITOS) - Bozor qiymati|Bozor kapitallashuvi OCEA|TCBP (TC BioPharm (Holdings) PLC) - Bozor kapitallashuvi|Bozor qiymati Third Harmonic Bio Inc THRD
